Vericel

VCEL NASDAQ
18.47
-0.26
-1.39%
After Hours: 18.47 0 0.00% 16:25 07/22 EDT
Open
18.83
Prev Close
18.73
High
18.90
Low
18.38
Volume
258.97K
Avg Vol (3M)
533.64K
52 Week High
21.01
52 Week Low
9.70
% Turnover
0.59%
Market Cap
811.04M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Vericel VCEL stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Vericel Corporation is an integrated, commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. The Company operates through the research, product development, manufacture and distribution of cellular therapies for use in the treatment of specific diseases.. Its autologous cell therapy products include Epicel (cultured epidermal autografts), which is a permanent skin replacement for the treatment of patients with deep-dermal or full-thickness burns. The Company is developing MACI, which is a third-generation autologous chondrocyte implant and ixmyelocel-T, which is a patient-specific multicellular therapy.
MORE >

Recently

Name
Price
%Change